Sign in
4

Changes in Ownership

Protagenic Therapeutics, Inc.new Filed Acc 0001493152-20-013712

Options or other derivatives

  • Chief Financial Officer acquired 124,998 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Arrow Alexander K. Chief Financial Officer 2020-07-18 Grant or award · PTIX Common stock Options +124,998 $1.75 $218,747 124,998 D
Loading xslF345X03/ownership.xml…